R&D Systems™ Recombinant Human Livin alpha Protein

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Inhibition Activity

Supplier:  R&D Systems™ 1161LV100

Catalog No. 1161LV100

Description

Measured by its ability to reverse the inhibition of DEVD-AFC cleavage activity in cell extracts activated by addition of cytochrome c and dATP. The ED50 for this effect is 0.5-2.0 μM. Optimal dilutions should be determined by each laboratory for each application.

Specifications

• Accession Number: Q96CA5
• Formulation: Supplied as a 0.2 μm filtered solution in HEPES, NaCl, DTT and Glycerol.
• Molecular Weight (g/mol): M.W. (Observed): 38 kDa, reducing conditions; M.W. (theoretical): 34 kDa
• Quantity: 100 μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 3 months, -20°C to -70°C under sterile conditions after opening.
• Endotoxin Concentration: <1.5 EU / 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Purity or Quality Grade: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

• For Use With (Application): Inhibition Assay
• Gene ID (Entrez): 79444
• Name: Livin α/KIAP
• Source: E. coli-derived human Livin protein Met1-Ser298, with a C-terminal 6-His tag
• Structural Form: Monomer
• Gene Symbol: BIRC7
• Recombinant: Recombinant
• Protein: Livin